The symptoms of 86 patients referred to a district terminal care support team were rated throughout care using a standardized schedule. Pain was the most common main symptom at referral, occurring in 35 (41%) of the patients. The assessment scores for pain showed significant improvements after one week of care (P< 0.01) and there was a further improvement into the week of death. However, towards death, 18 (21 %) patients developed dyspnoea as their main symptom, and this became the most severe symptom at death. The symptom assessment scores for patients with dyspnoea showed no change over time, suggesting that existing methods to control dyspnoea are ineffective and that new interventions are needed.
Introduction
Cancer patients often suffer severe symptoms in the terminal period. Over the last 20 years the hospice movement has expanded and now provides care for dying cancer patients in inpatient and home settings. The domiciliary, hospice or hospital based teams that have been established apply current practice in the diagnosis, assessment and control symptomsv'' and are often identified specifically as 'symptom control and support teams'5.6.
The symptom most feared, and requiring alleviation in cancer patients is pain", The hospice movement has placed a great emphasis on pain control. In reference texts it occupies three times the space and discussion of any other symptoms 1 ,3.5. A study at St Christophers' Hospice showed that pain was the most common symptom, reported as 'a problem' in 76% of patients on admission'', Cartwright showed that common distressing symptoms retrospectively reported by the relatives of dying patients were both pain (42%) and trouble with breathing (28%)9. Large, prospective studies of symptom control have tended to concentrate on pain 10.11 , but smaller studies with fewer patients have included symptoms of intestinal obstruction'v-", ascites'? and lymphoedema" and have often focused on specific management in inpatient settings. None have considered the development of different symptoms during care or the degree of control of different symptoms.
We describe the results of a prospective study of symptoms in patients referred to the Bloomsbury Support Team. Bloomsbury Health Authority, a central London health district with a population of 130000, established in May 1982 16 a multidisciplinary symptom control and support team, consisting of a part-time doctor, two specialist nurses, a social worker, a secretary and a consultant in / radiotherapy and oncology. The team is primarily domiciliary and offers support and advice for terminally ill cancer patients, their families and community and hospital staff within the district 5 • 16, but does not take over responsibility for clinical care.
Patients and methods

Measuring symptoms
The study was part of continuing research to describe and evaluate the work of terminal care support teams using a standardized measurement instrument, the 'Support Team Assessment Schedule' (STAS)17.18. The STAS records a series of items which have been agreed by support teams to be independent objectives of care and measures of the condition and further needs of dying patients and their families. In the preliminary research reported here, 14 items, including aspects concerned directly with the patient and family and aspects concerned with the services were included. The Bloomsbury team chose to grade each item on a seven point scale (0-6). Definitions for the score level of each item were agreed and documented.
Symptoms were considered by two measures. First, the team recorded the main symptom in each week of care. Second, one of the care items recorded in the STAS is 'symptom control'. Table 1 shows the definition for symptom control scoring. High scores indicate many problems, low scores few problems.
Patients
Data were collected on all 124 patients referred to the Bloomsbury Support team between December 1984 and December 1985. The patient's diagnostic, There was a wide variety of other reasons for referral: patient support was the next most frequent (listed as a first or second reason in 23 (27%) patients).
demographic and social details were recorded at referral, and the main reasons for referral were noted from the referral request. The team then rated each patient and family .according to STAS. They scored the state of each newly accepted patient, at first assessment, and then at each weekly team meeting until the patient's death.
Patients still alive were followedfor 10 months until October 1986. Thirty-eight patients who died before two consecutive assessments could be made, or who were not in contact with the team in their last week of life, or who were still alive, have been excluded from this initial analysisIS, leaving a study group of 86 patients.
The analysis considered the percentage of patients with each main symptom and the mean scores (with associated 95% confidence intervals). Comparisons were made using paired t-tests, Mann-Whitney U-tests or Wilcoxon signed rank tests (in the case of paired data), as appropriate 19 -21 • Chi-square was used for the analysis of contingency tables. A probability of less than 0.05 was taken as significant, using twotailed tests. Table 2 shows the main symptoms for patients with different diagnoses at referral, during care and in the week of death. Pain was the most common (35 (41%) patients) main symptom at referral, but became less prominent over time. By contrast, after the first week of care there were more patients with no symptoms and more patients with weakness or dyspnoea as their main symptom. In the last week of care (the week of death), weakness and dyspnoea were the most common symptoms (19 and 18 patients, respectively); over 17% (15) of patients had no symptoms.
Main symptoms
In patients with lung cancer, the main symptoms at referral were most commonly pain and dyspnoea. During care the lung cancer patients developed dyspnoea more frequently than any other patients. In contrast patients with gastrointestinal cancers often presented with pain at referral and no patients in this group developed dyspnoea. Of the 18 patients with dyspnoea at death, most (14) had primary lung carcinomas.
Over half of the 18 patients with dyspnoea at death had dyspnoea at referral. The 13 patients with dyspnoea as their main symptom at referral all had dyspnoea as their main symptom at death. They were referred much closer to death than other patients (Table 3 ) and just less than half had died within two weeks of care. Patients with pain as their main and in the week of death it remained much the same at 2.04 (1.70-2.37). The scores for symptom control showed statistically significant reductions between the assessments at referral and in the last week of care (paired t-test, t=4.91, 85 d.f.; Wilcoxon, t= 1789.5; P< 0.005 in both cases). Figure 1 examines the symptom control scores separately for patients with pain, dyspnoea, weakness and other symptoms for the weeks at the beginning and end of care. Patients with a zero score, indicating no symptoms (and thus no main symptom) in any week have been excluded. The scores suggest that pain was controlled very early in care, while dyspnoea was not controlled at all. At referral, pain was the most common and most severe main symptom: 18 patients had moderate or severe pain with symptom control scores of 4 or above. Figure 1 shows that the assessment scores for patients with pain as the main symptom showed significant improvements during care. Compared with the scores at referral there was a significant reduction by the second week of care, which increased in the penultimate and was maintained in the last weeks of care. In the final week all the patients still with pain as the main symptom had assessment scores in the 1-3 range (mild to moderate); no patient scored 4 or more (moderate to severe).
Discussion
In this series of patients, pain was the most common severe main symptom at referral; in just under half of the patients. This is similar to the incidence of pain found in other studies':", Few studies have considered the degree of pain control by a support team at home. Parkes? in a retrospective comparison of home, hospital and hospice care for cancer patients with spouses found that bereaved relatives reported higher levels of pain for patients at home, even when a support team had been involved in care. Our findings, in a prospective study, showed that pain control was improved after one week of support team care, and further improvement was maintained until death. No patient died with severe pain.
Reports of the prevalence of dyspnoea vary. Twycross, defining dyspnoea (as used in this study) as an 'unpleasant awareness of the need for an increase in pulmonary ventilation and/or increased difficulty in ventilation', suggested dyspnoea was present in 30% of all terminal cancer and 65% of bronchogenic cancers/. Others have found dyspnoea more common in different settings. At St Christopher's Hospice, London, 47% of patients were reported as short of breath on admission''; and at St e, Toseph's Hospice, London, 48% of patients on admission were reported as dyspnoeic'P, Reuben and Mor, considering patients in the large longitudinal study of different forms of hospice care in the United States, showed dyspnoea to be present in 70% of terminal cancer patients at some time during the last six weeks of life 23 • As in our study, the prevalence of dyspnoea was found to increase as patients approached death. In the last weeks of life we found that one quarter of patients in the support team's care had dyspnoea as the main symptom. This supports Reuben and Mor's finding that 28% of terminal cancer patients had dyspnoea graded as 'at least moderate'<. In the Scores were different for patients with dyspnoea as the main symptom. The scores showed a nonsignificant trend of reduction between the week of referral and the week before death (r-test, t= 1.73,29 d.f.; Mann-Whitney U=248.50; 0.05<P<0.10 in both cases) but the scores increased again in the last week of life. Patients with weakness as the main symptom had lower scores than the patients with pain or dyspnoea at referral. During care there was a slight (non-significant) trend showing a reduction in the scores of patients with weakness. The scores of patients with other main symptoms showed no trend. 
Main Symptoms
Dyspnoea Pain last days of life we found that dyspnoea was the most common severe main symptom.
Dyspnoea has often been considered as 'a difficult problem" in terminal care settings. It has a variety of underlying causes. It can be related to the presence of tumour in the lung; effusionts), consolidation, replacement offunctioning lung by cancer, atelectasis; or to the effects of lymphangitis or ascites; or related to treatment (post-radiation fibrosis or postpneumonectomy); or to debility (commonly anaemia); or to underlying lung disease (commonly chronic obstructive pulmonary disease, asthma and heart failure)2.22. Any combination of these factors can apply. The patient's anxiety during breathless attacks frequently enhances the dyspnoea.
There are a variety of recommended treatments depending on the cause. These include therapy with opioids, bronchodilators (especially nebulized), anxiolytics, corticosteroids, oxygen and to reduce disease in certain cases, antibiotics, hormone, chemotherapy and radiotherapy. Discussion and explanation are always important". The treatments are applied by home care support teams 2,5,22 but our results suggest that treatment may not be sufficiently effective. The existing measures may have poor efficacy, or they may be applied too late. The Bloomsbury Support team became more aware of uncontrolled dyspnoea when these initial findings were reported.
Symptom control is a main reason for referral for terminal care support, and a major objective of support teams. Uncontrolled dyspnoea appears to need greater attention. However, patients with dyspnoea as the main symptom are generally also referred later than other patients. We need to know whether dyspnoea is unrecognized by physicians and surgeons in terminal illness or whether dyspnoea has a later onset than pain.
